Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing moxidectin, sarolaner and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs

[1]  D. Woods,et al.  Preventive efficacy of oral moxidectin at various doses and dosage regimens against macrocyclic lactone-resistant heartworm (Dirofilaria immitis) strains in dogs , 2019, Parasites & Vectors.

[2]  D. Bowman,et al.  ProHeart® 12, a moxidectin extended-release injectable formulation for prevention of heartworm (Dirofilaria immitis) disease in dogs in the USA for 12 months , 2019, Parasites & Vectors.

[3]  T. Geary,et al.  Perspectives on the utility of moxidectin for the control of parasitic nematodes in the face of developing anthelmintic resistance , 2019, International journal for parasitology. Drugs and drug resistance.

[4]  S. Crosara,et al.  Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease. , 2018, Veterinary parasitology.

[5]  J. Mccall,et al.  Efficacy of oral moxidectin against susceptible and resistant isolates of Dirofilaria immitis in dogs , 2017, Parasites & Vectors.

[6]  D. Bowman,et al.  Evaluation of the efficacy of ProHeart® 6 (moxidectin) against a resistant isolate of Dirofilaria immitis (JYD-34) in dogs , 2017, Parasites & Vectors.

[7]  J. Xia,et al.  Genetic profiles of ten Dirofilaria immitis isolates susceptible or resistant to macrocyclic lactone heartworm preventives , 2017, Parasites & Vectors.

[8]  M. Rust.  The Biology and Ecology of Cat Fleas and Advancements in Their Pest Management: A Review , 2017, Insects.

[9]  J. Cherni,et al.  Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States. , 2016, Veterinary parasitology.

[10]  S. Grace,et al.  Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs. , 2016, Veterinary parasitology.

[11]  R. Farkas,et al.  Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe. , 2016, Veterinary parasitology.

[12]  W. Everett,et al.  Efficacy of a novel oral formulation of sarolaner (Simparica™) against five common tick species infesting dogs in the United States. , 2016, Veterinary parasitology.

[13]  C. Becskei,et al.  Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs. , 2016, Veterinary parasitology.

[14]  B. Blagburn,et al.  Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis , 2016, Parasites & Vectors.

[15]  C. Reinemeyer.  Formulations and Clinical Uses of Pyrimidine Compounds in Domestic Animals , 2016 .

[16]  C. Kleinman,et al.  Macrocyclic lactone resistance in Dirofilaria immitis: Failure of heartworm preventives and investigation of genetic markers for resistance. , 2015, Veterinary parasitology.

[17]  M. Murray,et al.  Heartworm 'lack of effectiveness' claims in the Mississippi delta: computerized analysis of owner compliance--2004-2011. , 2014, Veterinary parasitology.

[18]  J. Malone,et al.  Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs , 2014, Parasites & Vectors.

[19]  D. Bowman.  Heartworms, macrocyclic lactones, and the specter of resistance to prevention in the United States , 2012, Parasites & Vectors.

[20]  J. González-Miguel,et al.  Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic , 2012, Clinical Microbiology Reviews.

[21]  D. Traversa.  Pet roundworms and hookworms: A continuing need for global worming , 2012, Parasites & Vectors.

[22]  R. Prichard,et al.  Moxidectin and the avermectins: Consanguinity but not identity. , 2012, International journal for parasitology. Drugs and drug resistance.

[23]  A. R. Dillon,et al.  Comparative efficacy of four commercially available heartworm preventive products against the MP3 laboratory strain of Dirofilaria immitis. , 2011, Veterinary parasitology.

[24]  S. Wiseman,et al.  Ivermectin and milbemycin oxime in experimental adult heartworm (Dirofilaria immitis) infection of dogs. , 2011, Journal of veterinary internal medicine.

[25]  M. Alvinerie,et al.  Estimation of absolute oral bioavailability of moxidectin in dogs using a semi-simultaneous method: influence of lipid co-administration. , 2007, Journal of veterinary pharmacology and therapeutics.

[26]  J. Mccall.  The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations. , 2005, Veterinary parasitology.

[27]  A. Moritz,et al.  Development of a PCR-based diagnostic test detecting a nt230(del4) MDR1 mutation in dogs: verification in a moxidectin-sensitive Australian Shepherd. , 2005, Journal of veterinary pharmacology and therapeutics.

[28]  D. W. Fink,et al.  Pharmacokinetic studies of ivermectin: Effects of formulation , 1985, Veterinary Research Communications.

[29]  M. Dryden,et al.  Biology and control of ticks infesting dogs and cats in North America. , 2004, Veterinary therapeutics : research in applied veterinary medicine.

[30]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[31]  T. Nolan,et al.  Activity of an injectable, sustained-release formulation of moxidectin administered prophylactically to mixed-breed dogs to prevent infection with Dirofilaria immitis. , 2001, American journal of veterinary research.

[32]  Dr. Friederike Krämer,et al.  Flea Biology and Control , 2001, Springer Berlin Heidelberg.

[33]  W. Tranquilli,et al.  Safety of moxidectin in avermectin-sensitive collies. , 2000, American journal of veterinary research.

[34]  He-shuang Di,et al.  Chemoprophylactic effects of milbemycin oxime against larvae of Dirofilaria immitis during prepatent development. , 1991 .

[35]  V. A. Stewart,et al.  Chemoprophylactic effects of milbemycin oxime against larvae of Dirofilaria immitis during prepatent development. , 1991, American journal of veterinary research.

[36]  J. Sundberg,et al.  Efficacy of ivermectin against Dirofilaria immitis larvae in dogs 30 and 45 days after induced infection. , 1986, American journal of veterinary research.

[37]  C. Rawlings,et al.  Four types of occult Dirofilaria immitis infection in dogs. , 1982, Journal of the American Veterinary Medical Association.

[38]  W. M. Heller,et al.  The United States Pharmacopeial Convention, Inc , 1977 .